BIO International Convention 2024
The BIO International Convention is the largest and most comprehensive event for biotechnology, representing the full ecosystem of biotech with over 20,000 industry leaders from across the globe.
Whether you work at a public pharmaceutical company, biotech startup, academia, non-profits, and government or are a researcher, business development professional, or investor, BIO is where you'll make valuable connections and build relationships.
Attending the event? Be sure to catch Stephanie Fertig, Director, NIH Small Business Program, at the "Build Your Product Pipeline with Non-Dilutive Federal Resources" session on Tuesday, June 4, at 11:00 a.m. Session attendees will learn about the more than $1.3 billion available from NIH's seed fund, also known as the Small Business Innovation Research (SBIR) and Small Business Technology Transfer (STTR) programs, and more.
In addition, you'll be able to hear pitches and learn about these NIH-sponsored companies:
- Accuronix Therapeutics
- AAVogen
- Biopico Systems
- Concerto Biosciences
- Dermaxon
- Extend Biosciences
- GSNO Therapeutics
- Hillhurst Bio
- Immuto Scientific
- Indee Labs
- InVivo Biosystems
- Invivo Sciences
- Kannalife
- Kayothera
- Lectenz Bio
- Lynthera
- Medosome Biotec
- MODALITY.AI
- Novoron Bioscience
- Pelagos Pharmaceuticals
- Pirouette Medical
- Reveal Pharmaceuticals
- Sarcomatrix
- Sinopia Biosciences
- StemSynergy Therapeutics
- Talus Bioscience
- Tiba Biotech
- TransCode Therapeutics
- Ventrix Bio
- Vivacelle Bio
